InvestSMART

Memphasys Limited (ASX: MEM) - Share Price

- Current share price for MEM : $0.006

Memphasys Limited (MEM) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is a reproductive biotechnology company focused on the commercialisation of its patented Felix System, a novel bio-separation technology for assisted reproduction.

MEM General Information +

ASX Code MEM
Website N/A
Industry/Sector Life Sciences Tools & Services
Market Cap ($M) 18
MEM Share Price $0.006
Day High $0.006
Day Low $0.006
Last Close $0.006
MEM Share Price Movement - ( No change )
Prices as at 16:40, 18 Sep 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Memphasys Limited (MEM) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Memphasys Limited (MEM) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Memphasys Limited (MEM) price-sensitive announcements

MEM - Felix Registration Achieved in Vietnam and Cartridge Order
Memphasys Limited has successfully registered its Felix™ System in Vietnam as of August 20
Memphasys Limited (MEM)
20 Aug 2026 | 8:48 AM
MEM - European Commercial Roll-out continues with Poland Agreement
Memphasys Limited has entered an exclusive commercialisation agreement with TK Biotech Sp.
Memphasys Limited (MEM)
5 Aug 2026 | 8:44 AM
MEM - Quarterly Activities/Appendix 4C Cash Flow Report
Memphasys Limited reported significant commercial activity for the quarter ended 30 June 2
Memphasys Limited (MEM)
16 Jul 2026 | 9:00 AM
MEM - Exclusive Thailand Commercialisation Agreement Secured
Memphasys Limited has secured a three-year exclusive commercial distribution agreement wit
Memphasys Limited (MEM)
1 Jul 2026 | 8:48 AM

Memphasys Limited (MEM) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Memphasys Limited (MEM)
ORDINARY FULLY PAID
Health Care $19 Notification regarding unquoted securities - MEM 18 Sep 2026 4:27PM $0.006 $0.006 fallen by 0%
Memphasys Limited (MEM)
ORDINARY FULLY PAID
Health Care $19 Notification regarding unquoted securities - MEM 18 Sep 2026 4:22PM $0.006 $0.006 fallen by 0%
Memphasys Limited (MEM)
ORDINARY FULLY PAID
Health Care $19 Application for quotation of securities - MEM 18 Sep 2026 4:18PM $0.006 $0.006 fallen by 0%
Memphasys Limited (MEM)
ORDINARY FULLY PAID
Health Care $19 Memphasys Secures European Felix Agreement 18 Sep 2026 8:45AM $0.006 $0.006 fallen by 0%
Memphasys Limited (MEM)
ORDINARY FULLY PAID
Health Care $19 Memphasys Investor Webinar Presentation - September 2026 8 Sep 2026 9:01AM $0.007 $0.006 fallen by 7.69%
Memphasys Limited (MEM)
ORDINARY FULLY PAID
Health Care $19 Investor Webinar Invite 4 Sep 2026 11:41AM $0.006 $0.006 fallen by 0%

MEM Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2026A -$4.10 -$0.20 33.30% 0.00 0.00 0.00% 0.0%
2025A -$4.14 -$0.10 -33.30% 0.00 0.00 0.00% 0.0%
2024A -$4.44 -$0.20 5.90% 0.00 0.00 0.00% 0.0%

MEM Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2024 A 2025 A 2026 A 2024 A 2025 A 2026 A 2024 A 2025 A 2026 A
Memphasys Limited (MEM) $19M 0.3333 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

MEM Directors

Name Position Start Date
Mr David Raymond Tasker Non-Executive Chairman, Non-Executive Director 19 May 2026
Mr Marjan Mikel Non-Executive Director 19 Jun 2025
Mr Mathew Leslie Watkins Non-Executive Director 20 Oct 2025

Memphasys Limited (MEM) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
19 Dec 2025 MIKEL, Marjan Issued Direct Shares 6,666,667 $0.003 $20,000.000
19 Dec 2025 EDWARDS, Lindley Issued Direct Shares 5,848,840 $0.003 $17,546.520
30 Dec 2022 COUTTS, Alison Buy Indirect Shares 390,277 $0.014 $5,385.823

See all changes in directors' interest & trades for Memphasys Limited (MEM) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

MEM Management

Name Position
David Ali Chief Executive Officer
Andrew William Metcalfe Company Secretary
Stefan Ross Company Secretary

MEM Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Memphasys Limited (MEM). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
287,760,255 (14.51%) Andrew Ernest Goodall
261,564,791 (13.19%) Peters Investments Pty Ltd

MEM Calendar of Events

Date Event
30 August 2027 Report (Annual)
30 August 2027 Report (Prelim)
26 February 2027 Report (Interim)
25 November 2026 AGM
29 September 2026 Report (Annual)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.